An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia by.

Slides:



Advertisements
Presentazioni simili
Definition of COPD Chronic obstructive pulmonary disease (COPD) is a disease state characterized by airflow limitation that is not fully reversible. The.
Advertisements

LE COMPLICANZE INFETTIVE NEI PAZIENTI CON LEUCEMIA LINFATICA CRONICA (LLC) LE INFEZIONI RIMANGONO UNA DELLE PRINCIPALI CAUSE DI DI MORBIDITA’ E MORTALITA’
PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects Enrico Patrucco, Antonella Notte,
Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia by Andrea Pession, Riccardo Masetti,
Studi con Abraxane in combinazione con schedula settimanale: dati di efficacia e tollerabilità
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the.
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation by Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo.
Genome Search in Celiac Disease Luigi Greco, Gino Corazza, Marie-Claude Babron, Fabienne Clot, Marie-Claude Fulchignoni-Lataud, Selvaggia Percopo, Patrizia.
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study by Sara Bringhen, Maria.
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients by Sara Bringhen, Alessandra Larocca, Davide Rossi, Maide Cavalli, Mariella.
Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party.
Identification of a New Locus for Medullary Cystic Disease, on Chromosome 16p12 Francesco Scolari, Daniela Puzzer, Antonio Amoroso, Gianluca Caridi, Gian.
Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi- Center Randomized Clinical Trial by Angela Vitrano,
PET/CT Is a Useful Tool For Both Refining The Definition Of Complete Response (CR) In Multiple Myeloma (MM) and Detecting Otherwise Unrevealed Progression.
Randomized Trial of Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine As Preparative Regimen to Allogeneic Hematopoietic Stem Cell Transplantation.
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo.
Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint Tiziana Bruno, Francesca De Nicola, Simona Iezzi,
Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele.
UP-TO-DATE SULL’ISCHEMIA CRITICA Influenza dei fattori di rischio Andrea Semplicini Medicina Interna 1 - Ospedale di Venezia Azienda ULSS 12 Veneziana.
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia by Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio,
Lucia Del Mastro Gruppo Italiano Mammella - GIM Napoli 10 marzo 2017
Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience  Roberto Lorusso,
American Heart Journal
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease  Federico Conrotto, MD, Stefano Salizzoni, MD, Alessandro Andreis,
How to manage children who have come into contact with patients affected by tuberculosis  Laura Lancella, Andrea Lo Vecchio, Elena Chiappini, Marina Tadolini,
Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: Clinical outcome according to KRAS and BRAF mutational.
Volume 126, Issue 5, Pages (November 2004)
EVEROLIMUS ASSOCIATO A DOSI MOLTO BASSE DI CYA DETERMINA ELEVATO GFR RISPETTO AL TRATTAMENTO STANDARD AIDA LARTI E. Bertoni, G. Rosso, L. Di Maria, M.
Heart failure and anemia: Effects on prognostic variables
Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: The INtegrilin plus STenting to Avoid myocardial.
Volume 146, Issue 4, Pages (October 2014)
Volume 126, Issue 1, Pages (January 2004)
Critical Reviews in Oncology / Hematology
Volume 119, Issue 1, Pages (July 2000)
Growth trend of small uterine fibroids and human chorionic gonadotropin serum levels in early pregnancy: an observational study  Andrea Ciavattini, M.D.,
Persistent Improvement In Clinical Outcomes With Bortezomib-Thalidomide-Dexamethasone Vs Thalidomide-Dexamethasone Incorporated Into Double Autologous.
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma by Luca Ceriani, Maurizio.
Bendamustine, Low-Dose Dexamethasone, and Lenalidomide (BdL) For The Treatment Of Patients With Relapsed Multiple Myeloma Confirms Very Promising Results.
Positive Selection and Transplantation of Autologous Highly Purified CD133+ Stem Cells in Resistant/Relapsed Chronic Lymphocytic Leukemia Patients Results.
Long-Term Outcome After Antiviral Therapy of Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis  Angelo Iacobellis, Francesco Perri,
V. Cento, S. Barbaliscia, I. Lenci, T. Ruggiero, C. F. Magni, S
The Limadou project on the CSES space mission:
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft– Allograft in Multiple Myeloma  Luisa Giaccone, Andrea Evangelista, Francesca.
Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors in Multiple Myeloma: Study from the Italian Bone Marrow Donor Registry  Roberto Passera,
The Long-Term Outcome Of Adult Patients With Acute Myeloid Leukemia NPM+ and FLT3/ITD- Is Not Significantly Improved By The Application Of An Allogeneic.
Safety for Patients With Celiac Disease of Baked Goods Made of Wheat Flour Hydrolyzed During Food Processing  Luigi Greco, Marco Gobbetti, Renata Auricchio,
NF1 Gene Mutations Represent the Major Molecular Event Underlying Neurofibromatosis-Noonan Syndrome  Alessandro De Luca, Irene Bottillo, Anna Sarkozy,
Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies  Javid Gaziev, Simone Marziali,
Use of office hysteroscopy to empty a very large hematometra in a young virgin patient with mosaic Turner’s syndrome  Attilio Di Spiezio Sardo, M.D.,
Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic.
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies  Giuseppe.
Gastrointestinal Endoscopy
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection  Giulia Fiorini, Nimish Vakil,
Diagnostic Performance of Low-Dose Computed Tomography Screening for Lung Cancer over Five Years  Giulia Veronesi, MD, Patrick Maisonneuve, DipEng, Lorenzo.
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with.
Growth trend of small uterine fibroids and human chorionic gonadotropin serum levels in early pregnancy: an observational study  Andrea Ciavattini, M.D.,
Lanosterol Synthase Genetic Variants, Endogenous Ouabain, and Both Acute and Chronic Kidney Injury  Rossella Iatrino, Chiara Lanzani, Elena Bignami, Nunzia.
A randomized study on eversion versus standard carotid endarterectomy: Study design and preliminary results: The Everest Trial  Piergiorgio Cao, MD, Giuseppe.
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo.
Discoid or segmental rectosigmoid resection for deep infiltrating endometriosis: a case- control study  Francesco Fanfani, M.D., Anna Fagotti, M.D., Maria.
Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic.
Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study  Daniela Romualdi, M.D., Barbara.
MITO 31 A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA mutations: a MITO translational.
High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for “De Novo” Multiple Myeloma Patients:
Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience  Roberto Lorusso,
Gastrointestinal Endoscopy
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy  Chiara Messina, Marco.
Age-sex–specific ranges of platelet count and all-cause mortality: prospective findings from the MOLI-SANI study by Marialaura Bonaccio, Augusto Di Castelnuovo,
Recommendations for the Analysis of ALK Gene Rearrangements in Non–Small-Cell Lung Cancer: A Consensus of the Italian Association of Medical Oncology.
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study by Sara Bringhen, Maria.
Transcript della presentazione:

An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia by Marco Montillo, Alessandra Tedeschi, Valeria Belsito Petrizzi, Francesca Ricci, Monica Crugnola, Mauro Spriano, Pierangelo Spedini, Fiorella Ilariucci, Lilj Uziel, Immacolata Attolico, Eleonora Vismara, Angelo De Blasio, Alfonso Zaccaria, and Enrica Morra Blood Volume 118(15):4079-4085 October 13, 2011 ©2011 by American Society of Hematology

PFS and OS of patients receiving FCC. (A) PFS in responders. PFS and OS of patients receiving FCC. (A) PFS in responders. (B) PFS according to response (CR vs PR). (C) OS in all 43 enrolled patients. (D) OS in responders. Marco Montillo et al. Blood 2011;118:4079-4085 ©2011 by American Society of Hematology